On Tuesday, Nov. 2, 2021, the Centers for Disease Control and Prevention (CDC) endorsed a low-dose version of the Pfizer-BioNTech COVID-19 vaccine for children ages 5-11. The approved vaccine is one-third of the amount given to adults. With the CDC’s green light, parents can now seek vaccinations for their children immediately. The Food and Drug…
On Wednesday, Oct. 20, 2021, the Food and Drug Administration (FDA) authorized both Moderna and Johnson & Johnson (J&J) COVID-19 vaccine booster shots. The agency also authorized the use of “mixing and matching” any of the three available COVID-19 vaccines, including the Pfizer-BioNTech version. In other words, if an individual has received a full dose…
The Centers for Disease Control and Prevention (CDC) recently issued a statement recommending a distribution plan for booster shots of the Pfizer-BioNTech COVID-19 vaccine. The agency recommends a booster dose for specific vulnerable populations and those in high-risk occupational and institutional settings. This guidance comes as CDC Director Rochelle P. Walensky endorsed the agency’s Advisory…
President Joe Biden’s administration is continuing its efforts to curb the COVID-19 pandemic and the spread of the deadly coronavirus Delta variant. Recently, the White House ordered all federal workers and contractors to get vaccinated against COVID-19. Now, the government is imposing a similar requirement on private employers. The move is estimated to affect over…
On Monday, Aug. 23, 2021, the Food and Drug Administration (FDA) gave full approval to the Pfizer-BioNTech coronavirus vaccine. It is the first full approval of any coronavirus vaccine in the United States. The other vaccines, Moderna and Johnson & Johnson, are still available under emergency use authorization (EUA) granted by the FDA. The Moderna…